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Abstract
This paper presents the results of measurements of 99mTc activity concentrations in indoor air in a nuclear medicine depart-
ment and resulting estimated 99mTc intake by medical personnel. 99mTc air activity measurements were conducted at the 
Nuclear Medicine Department, John Paul II Hospital, Krakow, Poland, during ventilation–perfusion SPECT lung scans. 
Technetium from the air was collected by means of a mobile aerosol sampler with a Petryanov filter operating at an average 
flow rate of 10 dm3 min−1. Measured activities ranged from 99 ± 11 to 6.1 ± 0.5 kBq m−3. The resulting daily average intake 
of 99mTc by medical staff was estimated to be 5.4 kBq, 4.4 kBq, 3.0 kBq and 2.5 kBq, respectively, for male technicians, 
female technicians, male nurses and female nurses. Corresponding annual effective doses were 1.6 µSv for technicians and 
1 µSv for nurses. The highest equivalent dose values were determined for extrathoracic (ET) airways: 5 µSv and 10 µSv for 
nurses and technicians, respectively. It is concluded that estimated annual absorbed doses are over three orders of magnitude 
lower than the dose limit established in the Polish Atomic Law Act and in recommendations of the International Commission 
on Radiological Protection for medical staff.
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Introduction
Technetium (Tc) is a chemical element belonging to the 
seventh group of the periodic table (transition metal). Pri-
marily, Tc is obtained artificially by fission processes of 
heavy nuclei, but it is also present in the Earth’s crust due 
to spontaneous fission in uranium and thorium ores. There 
are 32 radioactive isotopes and 11 metastable isomers of 
technetium known at this moment.
One of the isotopes of technetium, namely 99mTc, is fre-
quently used in nuclear medicine, especially in diagnostics 
with the Single-Photon Emission Computed Tomography 
(SPECT) imaging technique. Physicochemical properties 
such as low energy of the gamma-rays emitted during decay 
(140.5 keV, emission probability p = 99%), short physical 
half-life of 6.01 h and rich co-ordination chemistry (which 
allows creation of many useful chemical complexes) are the 
reasons for the wide-spread use of 99mTc in a wide range of 
diagnostic applications. It has been estimated that 99mTc is 
the most frequently applied radioactive isotope for examina-
tions in nuclear medicine (IAEA 2008).
A ventilation–perfusion lung scan is one of the medical 
imaging methods in which 99mTc is applied. This examina-
tion consists of two lung scans. The first part, the perfu-
sion scan, allows assessment of the lungs’ blood supply and 
requires intravenous injection of technetium macro aggre-
gated albumin containing 150 MBq of 99mTc. The second 
scan, the pulmonary ventilation scan, allows examination of 
the patency of the bronchial tree and lungs. Before scanning, 
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a gas containing 400–500 MBq of 99mTc is inhaled by the 
patient through a mouthpiece or mask covering the nose and 
mouth. In the medical routine, technetium DTPA (diethylen-
etriaminepentaacetic acid) or Technegas (ultrafine dispersion 
of 99mTc-labeled carbon) is used as a source of the radionu-
clide (Jogi et al. 2010).
At the time or shortly after inhalation of gaseous radio-
active technetium, part of the 99mTc activity may leak into 
the room air and pose an additional risk of radiation bur-
den for medical staff who perform examinations. To verify 
this hypothesis, a series of measurements of 99mTc activity 
in the air were performed. The experiment was carried out 
in a nuclear medicine department, during routine ventila-
tion–perfusion lung scans.
Materials and methods
Location
The present study was conducted at the Nuclear Medicine 
Department, John Paul II Hospital in Krakow, Poland. This 
unit is specialized in SPECT diagnostics and is supplied 
with a Siemens Symbia T16 SPECT/CT hybrid device. The 
following treatment protocols are routinely performed: myo-
cardial perfusion imaging, bone scintigraphy, renoscintigra-
phy, and ventilation–perfusion lung scans. The medical staff 
consists of nine specialists (three technicians, four nurses 
and two physicians).
The department is also equipped with a Cyclomedica 
Technegas generator that is utilized in the routine inhala-
tion procedure. The department usually performs ventila-
tion–perfusion lung scans once per week on Tuesday. Four 
patients per day and about 200 patients per year are usually 
diagnosed in the department.
Aerosol sampling and measurement
99mTc activity concentration measurements were carried out 
during ventilation–perfusion lung scans on one specific day 
(10th September 2018). The experiment included collection 
of aerosol samples in two rooms—the first was a room with a 
SPECT camera and Technegas generator (called the acquisi-
tion room) and the second was a control room. The layout 
of the rooms is presented in Fig. 1. In each of the rooms, ten 
samples were gathered every 40 min to 1 h.
The rooms where the experiment was conducted were 
equipped with ventilation systems. Air exhaust rates were 
1085 m3 h−1 and 60 m3 h−1, which gave ventilation efficien-
cies of about 8.5 and 2 air changes per hour for the acquisi-
tion and control room, respectively. During routine work, 
medical staff enters the acquisition room about twice per 
treatment, which results in additional ventilation of that 
room. The change of air volume due to door opening is dif-
ficult to estimate, but the authors believe that it is negligible 
compared with the highly efficient ventilation system.
Aerosols from the air were collected by means of a 
mobile aerosol sampler that operated at an average flow rate 
of 10 dm3 min−1. Aerosols were captured using a Petryanov 
filter FPP-15-1.5 (poly(vinyl chloride)) manufactured by 
ESFIL TEHNO AS (Estonia). Those filters are commonly 
used for aerosol collection, due to their high collection effi-
ciency, which can reach up to 97% (Lipiński et al. 2013). 
Due to the short physical half-life of 99mTc, right after sam-
pling, filters were transported to the Institute of Nuclear 
Physics, Polish Academy of Science (Krakow, Poland). 
Subsequently, samples were compressed into pellets (5 cm 
diameter and about 4 mm height) and analyzed by means 
of a low-background gamma-ray spectrometer including a 
high-purity germanium (HPGe) detector manufactured by 
Ortec (GMX-30190-P, 30% relative efficiency). The elec-
tronics were based on NIM modules by Canberra and spec-
tra acquisition and analysis were performed with Canberra 
Genie 2000 software. To determine 99mTc activity collected 
on the Petryanov filter, the intensity of the 140 keV gamma-
ray line was measured. Efficiency calibration was done with 
a multi-gamma source SZN 40/10 by Polatom. The source 
Fig. 1  Layout of the rooms where air sampling was conducted
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had a disc-shaped geometry of 50 mm diameter and 5 mm 
height. The matrix density was 1.00 g cm−2. Such method 
has already been successfully applied for measurements of 
aerosol and gas activities over the past years (Mietelski et al. 
2005, 2014; Masson et al. 2011; Brudecki et al. 2018a).
Dose estimation
Based on the measured 99mTc activity concentrations in air, 
annual organ equivalent and effective doses for the techni-
cians and nurses were estimated. In the beginning, utilizing 
routine working schemes, the average time spent by medi-
cal staff in contaminated areas was established. To perform 
one test, the technician entered the acquisition room twice 
and spent about 5 min there each time, once to assist the 
patient during inhalation of radioactive technetium and then 
to position him/her on the imaging table. After treatment, the 
technician entered the acquisition room a second time and 
helped the patient to get up and leave the diagnostic room. 
The technician spent the remaining time in the control room. 
To carry out a perfusion scan, the nurse needed to enter the 
acquisition room to perform an intravenous injection, which 
lasted approximately 5 min. Routinely, there are four ventila-
tion–perfusion lung scans conducted in the department per 
day and week.
The next step involved estimation of the overall absorbed 
99mTc activities in the respiratory system and in other organs 
of the staff. Calculations were made using a biokinetic model 
of technetium recommended by the International Com-
mission on Radiological Protection (ICRP 2016) in com-
bination with the human respiratory tract model (HRTM) 
(ICRP 1994, 2002) and gastrointestinal tract model (GITM) 
(ICRP 1979), developed ICRP. Computer simulations were 
performed by means of the SAAM II software from the 
Epsilon Group. In line with ICRP recommendations, in the 
performed simulations, lung clearance of Technegas was 
assumed as a Type F (fast) (ICRP 2002). The Technegas 
system’s manufacturer ensures that the size of most of the 
produced aerosols is in the range of 30–60 nm (Cyclomedica 
2007). Therefore, the deposition of 99mTc aerosol fractions 
was calculated for an assumed activity median aerodynamic 
diameter (AMAD) of the attached aerosols of 50 nm. During 
work, the breathing rate of medical staff is adequate for light 
exercise. Aerosol deposition in HRTM for a 50 nm AMAD 
aerosol in light exercise is presented in Table  1. Other 
parameters used in the calculations are presented in Table 2.
Finally, doses were calculated based on the time-inte-
grated 99mTc activity (model of technetium biokinetics and 
computer simulations), radiation-weighted coefficients 
(SECALL program, Oak Ridge National Laboratory, Oak 
Ridge, TN, USA) and tissue-weighting factors according 
to the ICRP methodology (ICRP 2007). More details on 
the applied methodology of absorbed dose calculations are 
given in Li et al. (2008) and Brudecki et al. (2014, 2017a, 
b, 2018a, b).
Results and discussion
At the time of the experiment, 20 aerosol samples were 
collected, measured and analyzed. In the acquisition room, 
99mTc activity concentration varied from 99 ± 11 Bq m−3 to 
6.1 ± 0.5 kBq m−3. The activity of technetium systemati-
cally increased during the time the ventilation–perfusion 
lung scans were conducted. Soon after the last patient was 
examined, the concentration of 99mTc rapidly declined as a 
result of air changing due to the highly effective ventilation 
system and frequent opening of doors. The activity of tech-
netium in the control room reached 0.85 ± 0.07 kBq m−3, 
which is one order of magnitude lower than in the acquisi-
tion room. In addition, analysis of the samples collected 
before first utilization of the Technegas generator on the 
experiment day suggested that due to previous treatments 
conducted in the department, a constant radiation back-
ground from 99mTc on the level of about 0.1–0.2 kBq m−3 
Table 1  Aerosol deposition in the ICRP human respiratory tract 
model (HRTM) for a 50  nm activity median aerodynamic diameter 
(AMAD) and light exercise (ET1 extrathoracic region, ET2 posterior 
nasal passages, BB bronchial, bb bronchiolar, AI alveolar–interstitial) 
(ICRP 2002)
Region\exercise levels Light exercise
♀ Female ♂ Male
ET1 3.2 × 10−2 3.2 × 10−2
ET2 3.4 × 10−2 3.4 × 10−2
BB fast and seq 5 × 10−3 4.7 × 10−3
BB slow 5 × 10−3 4.7 × 10−3
bb fast and seq 3.8 × 10−2 3.4 × 10−2
bb slow 3.8 × 10−2 3.4 × 10−2
AI 3.1 × 10−1 3.1 × 10−1
Table 2  Ventilation parameters and activity assumed in the calcula-
tions
♀ female, ♂ male
Parameters\profession Technician Nurses
Exercise level Light exercise
Breathing rate  (m3 h−1) 1.2 ♀, 1.5 ♂
Daily intake (Bq) 4400 ♀, 5400 ♂ 2450 ♀, 3000 ♂
Type of absorption F (fast)
Intake frequency 1 day a week (on Tues-
day)
Number of annual 
intakes
50
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existed (first samples collected in each room). The detailed 
results are presented in Fig. 2. It should be noted that, 
taking into consideration the sample collection times as 
well as the highly efficient ventilation systems installed in 
the department rooms, short-term 99mTc activity concen-
trations may have significantly exceeded the determined 
values.
On the basis of the outcome of the 99mTc activity con-
centration measurements and taking into account the rou-
tine working time of technicians and nurses, daily activity 
intake was estimated. The results are as follows: 5.4 kBq, 
4.4  kBq, 3.0  kBq and 2.5  kBq, respectively, for male 
technicians, female technicians, male nurses and female 
nurses. Detailed results are presented in Fig. 3.
The last step in the present study was the estimation 
of the dose received by the medical team involved. The 
annual effective committed dose reached 1.8 μSv for tech-
nicians and 0.9 μSv for nurses. The highest equivalent 
annual doses were found in ET airways—10 μSv, 9.5 μSv, 
5.7 μSv and 5.3 μSv, respectively, for male technicians, 
female technicians, male nurses and female nurses. The 
Fig. 2  99mTc air activity concentration in acquisition room and con-
trol room. The results are presented with one sigma uncertainty
Fig. 3  Estimation of daily 99mTc intake: a male technician; b female technician; c male nurse; d female nurse. Area under curve: 5400  Bq, 
4400 Bq, 3000 Bq and 2450 Bq, respectively, for male technician, female technician, male nurse and female nurse
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fact that the dose for nurses (both sexes) was a factor of 
2 lower than that for technicians is the result of a shorter 
time of work in the contaminated area, namely, in the 
acquisition and control rooms. Detailed information is 
presented in Table 3.
Internal and external exposures of medical personnel 
due to 99mTc have been described in some previous publi-
cations. Krajewska and Pachocki (2013) reported activities 
of 99mTc in thyroids of examined medical staff in the range 
from 50 to 1800 Bq, with an average activity of 1500 Bq. 
Internal contamination was also studied by Ferdous et al. 
(2012) based on monitoring of 99mTc activity in urine sam-
ples. Their reported values ranged from 9 to 314 Bq L−1 
and corresponding doses varied from 0.4 to 15  μSv. 
Similar examinations were performed by Greaves et al. 
(1995) who collected 24 air samples during ventilation 
and imaging tests. They found an average 99mTc activity 
concentration in air of 4.4 kBq m−3, which implied a daily 
effective dose to medical staff of 0.004 µSv. These authors 
reported also that 10 min after inhalation, 99mTc activ-
ity concentrations in air decreased to background level 
(except for two samples where the concentration was less 
than 1.1 kBq m−3).
External dose rates reported by Smart (2004) for tech-
nicians working with 99mTc were up to 100 μSv h−1. This 
value is similar to 43 μSv h−1 reported by Sattari et al. 
(2004). Another study (Forsa and Standen 2012) reported 
values of external radiation doses caused by 99mTc during 
various medical procedures, with an average of 1 nSv per 
MBq assumed as a representative value for Norwegian 
nuclear medicine departments. Direct comparison of both 
Table 3  Estimated annual organ equivalent and effective committed doses (given in Sv)
St stomach SI small intestine, ULI upper large intestine, LLI lower large intestine, ET extrathoracic, GB gallbladder, HT heart
Technician Nurse
♀ Female ♂ Male ♀ Female ♂ Male
Daily Annual Daily Annual Daily Annual Daily Annual
Adrenals 8.2 × 10−9 4.1 × 10−7 8.1 × 10−9 4.0 × 10−7 4.6 × 10−9 2.3 × 10−7 4.5 × 10−9 2.2 × 10−7
Bladder wall 3.4 × 10−8 1.7 × 10−6 3.2 × 10−8 1.6 × 10−6 1.9 × 10−8 9.4 × 10−7 1.8 × 10−8 8.9 × 10−7
Bone surfaces 1.8 × 10−8 8.8 × 10−7 1.7 × 10−8 8.6 × 10−7 9.8 × 10−9 4.9 × 10−7 9.6 × 10−9 4.8 × 10−7
Brain 2.6 × 10−9 1.3 × 10−7 2.7 × 10−9 1.4 × 10−7 1.4 × 10−9 7.1 × 10−8 1.5 × 10−9 7.6 × 10−8
Breasts 2.8 × 10−9 1.4 × 10−7 2.8 × 10−9 1.4 × 10−7 1.5 × 10−9 7.7 × 10−8 1.5 × 10−9 7.7 × 10−8
St wall 6.3 × 10−8 3.2 × 10−6 6.8 × 10−8 3.4 × 10−6 3.5 × 10−8 1.8 × 10−6 3.8 × 10−8 1.9 × 10−6
SI wall 6.2 × 10−8 3.1 × 10−6 6.5 × 10−8 3.3 × 10−6 3.4 × 10−8 1.7 × 10−6 3.6 × 10−8 1.8 × 10−6
ULI wall 1.5 × 10−7 7.3 × 10−6 1.6 × 10−7 8.0 × 10−6 8.1 × 10−8 4.1 × 10−6 8.9 × 10−8 4.4 × 10−6
LLI wall 9.9 × 10−8 4.9 × 10−6 1.1 × 10−7 5.6 × 10−6 5.5 × 10−8 2.8 × 10−6 6.2 × 10−8 3.1 × 10−6
Colon 1.3 × 10−7 6.3 × 10−6 1.4 × 10−7 7.0 × 10−6 7.0 × 10−8 3.5 × 10−6 7.7 × 10−8 3.9 × 10−6
Kidneys 1.7 × 10−8 8.3 × 10−7 1.8 × 10−8 8.8 × 10−7 9.3 × 10−9 4.6 × 10−7 9.7 × 10−9 4.9 × 10−7
Liver 1.6 × 10−8 8.1 × 10−7 1.6 × 10−8 7.9 × 10−7 9.0 × 10−9 4.5 × 10−7 8.8 × 10−9 4.4 × 10−7
Muscle 7.1 × 10−9 3.6 × 10−7 7.1 × 10−9 3.6 × 10−7 4.0 × 10−9 2.0 × 10−7 4.0 × 10−9 2.0 × 10−7
Ovaries 3.3 × 10−8 1.7 × 10−6 – – 1.8 × 10−8 9.2 × 10−7 – –
Pancreas 1.4 × 10−8 7.2 × 10−7 1.4 × 10−8 7.0 × 10−7 8.0 × 10−9 4.0 × 10−7 7.7 × 10−9 3.9 × 10−7
Red marrow 8.5 × 10−9 4.3 × 10−7 8.8 × 10−9 4.4 × 10−7 4.7 × 10−9 2.4 × 10−7 4.9 × 10−9 2.4 × 10−7
ET airways 1.9 × 10−7 9.5 × 10−6 2.0 × 10−7 1.0 × 10−5 1.1 × 10−7 5.3 × 10−6 1.1 × 10−7 5.7 × 10−6
Lungs 1.7 × 10−8 8.6 × 10−7 1.8 × 10−8 9.2 × 10−7 9.6 × 10−9 4.8 × 10−7 1.0 × 10−8 5.1 × 10−7
Skin 3.0 × 10−9 1.5 × 10−7 3.1 × 10−9 1.6 × 10−7 1.7 × 10−9 8.4 × 10−8 1.7 × 10−9 8.6 × 10−8
Spleen 9.6 × 10−9 4.8 × 10−7 9.8 × 10−9 4.9 × 10−7 5.3 × 10−9 2.7 × 10−7 5.4 × 10−9 2.7 × 10−7
Testes – – 4.1 × 10−9 2.1 × 10−7 – – 2.3 × 10−9 1.1 × 10−7
Thymus 4.3 × 10−9 2.1 × 10−7 3.9 × 10−9 2.0 × 10−7 2.4 × 10−9 1.2 × 10−7 2.2 × 10−9 1.1 × 10−7
Thyroid 7.9 × 10−8 3.9 × 10−6 8.3 × 10−8 4.2 × 10−6 4.4 × 10−8 2.2 × 10−6 4.6 × 10−8 2.3 × 10−6
GB wall 2.3 × 10−8 1.2 × 10−6 2.2 × 10−8 1.1 × 10−6 1.3 × 10−8 6.4 × 10−7 1.2 × 10−8 6.1 × 10−7
HT wall 5.9 × 10−9 2.9 × 10−7 5.7 × 10−9 2.8 × 10−7 3.3 × 10−9 1.6 × 10−7 3.2 × 10−9 1.6 × 10−7
Uterus 2.2 × 10−8 1.1 × 10−6 2.1 × 10−8 1.1 × 10−6 1.2 × 10−8 6.1 × 10−7 1.2 × 10−8 5.9 × 10−7
Remainder 8.3 × 10−9 4.2 × 10−7 8.4 × 10−9 4.2 × 10−7 4.6 × 10−9 2.3 × 10−7 4.7 × 10−9 2.3 × 10−7
Effective dose 3.5 × 10−8 1.8 × 10−6 3.5 × 10−8 1.8 × 10−6 2.0 × 10−8 9.8 × 10−7 2.0 × 10−8 9.8 × 10−7
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external and internal doses suggests that external exposure 
is responsible for most of the effective annual dose.
Conclusions
In the present study, 99mTc activity concentrations in 
indoor air of a nuclear medicine hospital, as well as result-
ing absorbed doses for medical staff, were estimated. The 
study involved measurement and analysis of 20 aerosol 
samples collected in both the acquisition room and control 
room in the Nuclear Medicine Department, John Paul II 
Hospital, Krakow, Poland, during ventilation–perfusion 
lung scans. Although the technetium activity in the air 
and the estimated 99mTc intakes seem to be quite high, 
corresponding annual effective doses are rather low. Fur-
thermore, calculated annual effective doses are over three 
orders of magnitude lower than the dose limit established 
in the Polish Atomic Law Act and recommended by the 
ICRP (corresponding to effective doses from 6 to 20 mSv 
per year). In the light of current knowledge, such doses do 
not pose any significant health risk for medical staff. How-
ever, the present study concerned only a small part of the 
daily working routine of medical personnel and, therefore, 
does not necessarily imply that 99mTc intake and associated 
doses will always be at sufficiently low and safe levels. 
Therefore, regular monitoring of internal contamination 
of hospital staff working with 99mTc is recommended. Fur-
thermore, it should be mentioned that conducting more 
measurements would be desirable; however, currently 
this is not feasible because the sample collection tech-
nique used in the present study is highly burdensome for 
both medical staff and patients. Due to this, the presented 
results must be interpreted with caution and should be 
seen just as a first indication of 99mTc exposure in current 
clinical practice.
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